Drug Information

Drug General Information
Drug ID
D0B2SW
Former ID
DIB002340
Drug Name
ASP-3291
Indication Ulcerative colitis [ICD9: 556; ICD10:K51] Phase 2 [523934]
Company
Astellas Pharma Inc
Target and Pathway
Target(s) Melanocortin receptor Target Info Modulator [550606]
References
Ref 523934ClinicalTrials.gov (NCT01612039) Safety, Efficacy, and Tolerability Study of ASP3291 in Patients With Active Ulcerative Colitis. U.S. National Institutes of Health.
Ref 550606Clinical pipeline report, company report or official report of Drais Pharmaceuticals.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.